|
|
| FAR6014 | Cardiovascular System Pharmacology | 2+0+2 | ECTS:7.5 | | Year / Semester | Fall Semester | | Level of Course | Third Cycle | | Status | Elective | | Department | DEPARTMENT of PHARMACOLOGY | | Prerequisites and co-requisites | None | | Mode of Delivery | | | Contact Hours | 14 weeks - 2 hours of lectures and 2 hours of laboratory per week | | Lecturer | Doç. Dr. Seçkin ENGİN | | Co-Lecturer | | | Language of instruction | Turkish | | Professional practise ( internship ) | None | | | | The aim of the course: | | To provide information about the pharmacological properties of drugs that affect the cardiovascular system, including their classification and mechanism of action. |
| Programme Outcomes | CTPO | TOA | | Upon successful completion of the course, the students will be able to : | | | | PO - 1 : | Can classify drugs that affect the cardiovascular system. | 1 - 2 - 3 - 4 - 5 | 1,3, | | PO - 2 : | Can explain the mechanisms of action of drugs that affect the cardiovascular system. | | 1,3, | | PO - 3 : | Knows the basic pharmacokinetic properties and side effects of drugs that act on the cardiovascular system. | | 1,3, | | PO - 4 : | Gains knowledge about experimental approaches related to cardiovascular system pharmacology. | | 1,3, | | CTPO : Contribution to programme outcomes, TOA :Type of assessment (1: written exam, 2: Oral exam, 3: Homework assignment, 4: Laboratory exercise/exam, 5: Seminar / presentation, 6: Term paper), PO : Learning Outcome | | |
| It contains pharmacological information about drugs that affect the cardiovascular system. |
| |
| Course Syllabus | | Week | Subject | Related Notes / Files | | Week 1 | Drugs used in the treatment of hypertension-1 | | | Week 2 | Drugs used in the treatment of hypertension-2 | | | Week 3 | Drugs used in the treatment of hypertension-3 and Animal models of experimental hypertension | | | Week 4 | Peripheral vasodilators | | | Week 5 | Antianginal drugs-1 | | | Week 6 | Antianginal drugs-2 and Experimental cardiac ischemia models | | | Week 7 | Antiarrhythmic Drugs | | | Week 8 | Experimental arrhythmia models | | | Week 9 | Midterm exam | | | Week 10 | Drugs used in the treatment of heart failure-1 | | | Week 11 | Drugs used in the treatment of heart failure-2 | | | Week 12 | Experimental models of heart failure | | | Week 13 | Medications used to treat dyslipidemia | | | Week 14 | Antithrombotic, anticoagulant, antiplatelet and thrombolytic drugs-1 | | | Week 15 | Antithrombotic, anticoagulant, antiplatelet and thrombolytic drugs-2 | | | Week 16 | Final exam | | | |
| 1 | Akılcıl Tedavi Yönünden Tıbbi Farmakoloji, 14. baskı | | | 2 | Goodman&Gilman Farmakoloji ve Tedavi El Kitabı, 2.baskı | | | |
| Method of Assessment | | Type of assessment | Week No | Date | Duration (hours) | Weight (%) | | Mid-term exam | 9 | Kasım 2025 | 2 | 25 | | In-term studies (second mid-term exam) | 11 | Aralık 2025 | 2 | 25 | | End-of-term exam | 16 | Ocak 2026 | 2 | 50 | | |
| Student Work Load and its Distribution | | Type of work | Duration (hours pw) | No of weeks / Number of activity | Hours in total per term | | Yüz yüze eğitim | 4 | 14 | 56 | | Sınıf dışı çalışma | 1 | 14 | 14 | | Laboratuar çalışması | 2 | 14 | 28 | | Arasınav için hazırlık | 2 | 8 | 16 | | Arasınav | 2 | 1 | 2 | | Ödev | 2 | 14 | 28 | | Proje | 2 | 14 | 28 | | Kısa sınav | 2 | 1 | 2 | | Dönem sonu sınavı için hazırlık | 2 | 6 | 12 | | Dönem sonu sınavı | 2 | 1 | 2 | | Total work load | | | 188 |
|